Skip to main content

Diagnosis of tuberculosis infection in pediatric patients treated with inhibitors of the tumour necrosis factor alpha. A multicenter national study comparing tuberculin skin test and igra tests

Introduction

In the last years, inhibitors of tumor necrosis factor alpha (antiTNFα) have been a major advance in the treatment of many rheumatic diseases and inflammatory bowel disease, also in the pediatric patient. However, antiTNFα use is associated with an increased risk of serious infections, including tuberculosis (TB). In adults, the new interferon γ release assays (IGRA) tests for the diagnosis of TB infection appear to show better sensitivity and specificity than the tuberculin skin test (TST) in these patients. Data in children are still very scarce. We have previously reported a latent tuberculosis infection (LTI) prevalence rate of 1.4% (95%CI: 0-2.9) in children on antiTNFα treatment, which is similar to that reported in healthy pediatric population studies in Spain. LTI was diagnosed in 3 adolescent girls (out of 221 patients) in whom QTF tested positive, while TST was positive in only one of them.

Objectives

To establish the sensitivity and specificity of IGRA tests in the diagnosis of LTI compared to the TST in pediatric patients by the implementation of antiTNFα treatment.

Methods

We present an ongoing national multicenter retrospective/prospective cross-sectional study (hosted by the Spanish National Societies of Pediatric Rheumatology, Infectious Diseases and Gastroenterology) including pediatric patients in whom LTI is to be ruled out simultaneously by TST and IGRA test, prior to initiating treatment with antiTNFα drugs. Medical history related to the underlying disease, the risk of LTI and the results of the TST and IGRA tests will be collected.

Conclusion

This study will observe the prevalence of LTI in this cohort, identify risk factors associated with LTI and analyze the sensitivity, specificity and negative predictive value of IGRA tests as compared to TST in children before antiTNFα initiation.

Disclosure of interest

None declared.

Author information

Authors and Affiliations

Authors

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Julian, A.N., López, J.A., Calzada-Hernández, J. et al. Diagnosis of tuberculosis infection in pediatric patients treated with inhibitors of the tumour necrosis factor alpha. A multicenter national study comparing tuberculin skin test and igra tests. Pediatr Rheumatol 12, P282 (2014). https://doi.org/10.1186/1546-0096-12-S1-P282

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/1546-0096-12-S1-P282

Keywords

  • Tuberculosis
  • Interferon
  • Inflammatory Bowel Disease
  • Pediatric Patient
  • Rheumatic Disease